Total Payments
$2,150
2020 Payments
$91.40
Companies
31
Transactions
138
Medicare Patients
2,451
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$2,150 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,150 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $369.83 | 24 | $0 (2018) |
| Amgen Inc. | $340.48 | 23 | $0 (2019) |
| Astellas Pharma US Inc | $149.52 | 10 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $145.16 | 11 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $118.86 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $112.01 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $109.71 | 8 | $0 (2019) |
| Varian Medical Systems, Inc. | $106.97 | 1 | $0 (2017) |
| Celgene Corporation | $77.98 | 5 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.76 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $91.40 | 5 | Astellas Pharma US Inc ($22.19) |
| 2019 | $525.60 | 36 | Amgen Inc. ($102.62) |
| 2018 | $901.02 | 61 | Novartis Pharmaceuticals Corporation ($225.12) |
| 2017 | $632.47 | 36 | Novartis Pharmaceuticals Corporation ($144.71) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 5 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Oncology | ||||||
| 01/10/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Anemia | ||||||
| 11/22/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Oncology | ||||||
| 11/15/2017 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Nephrology | ||||||
| 11/10/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Oncology | ||||||
| 11/08/2017 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Oncology | ||||||
| 11/07/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.34 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $12.61 | General |
| 10/23/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.82 | General |
| 10/04/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Oncology | ||||||
| 10/03/2017 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Oncology | ||||||
| 09/08/2017 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 08/30/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Oncology | ||||||
| 08/24/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Oncology | ||||||
| 08/08/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2017 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Nephrology | ||||||
| 07/28/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2017 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Nephrology | ||||||
| 07/10/2017 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 06/16/2017 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Oncology | ||||||
| 06/13/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 20 | 1,078 | 7,208 | $5.3M | $1.1M |
| 2020 | 24 | 1,373 | 9,107 | $6.1M | $1.2M |
Total Patients
2,451
Total Services
16,315
Medicare Billing
$2.3M
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2021 | 42 | 1,275 | $1.7M | $357,828 | 21.5% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2021 | 54 | 1,073 | $859,827 | $213,760 | 24.9% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Office | 2021 | 35 | 1,103 | $721,754 | $104,155 | 14.4% |
| 77427 | Radiation treatment management, 5 treatments | Office | 2021 | 89 | 455 | $283,733 | $67,392 | 23.8% |
| 77301 | Management of modulation radiotherapy planning | Office | 2021 | 31 | 36 | $254,375 | $51,079 | 20.1% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2021 | 46 | 901 | $338,150 | $50,513 | 14.9% |
| 77300 | Calculation of radiation therapy dose | Office | 2021 | 77 | 961 | $218,439 | $48,344 | 22.1% |
| 77336 | Radiation therapy consultation per week | Office | 2021 | 93 | 478 | $164,236 | $29,242 | 17.8% |
| 77280 | Management of radiation therapy simulation, simple | Office | 2021 | 58 | 121 | $114,790 | $26,233 | 22.9% |
| 77334 | Radiation treatment devices, design and construction, complex | Office | 2021 | 78 | 253 | $133,840 | $24,837 | 18.6% |
| 77290 | Management of radiation therapy, simulation, complex | Office | 2021 | 54 | 63 | $114,485 | $23,592 | 20.6% |
| 77295 | Management of radiation therapy, 3d | Office | 2021 | 40 | 42 | $165,443 | $15,870 | 9.6% |
| 77338 | Design and construction of device for radiation therapy | Office | 2021 | 31 | 36 | $59,418 | $13,149 | 22.1% |
| 77263 | Management of radiation therapy, complex | Office | 2021 | 76 | 84 | $48,617 | $10,783 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 81 | 81 | $44,143 | $10,652 | 24.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 144 | $34,281 | $9,616 | 28.1% |
| 77470 | Special radiation treatment procedure | Office | 2021 | 20 | 21 | $33,903 | $2,210 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 21 | $7,421 | $1,988 | 26.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 41 | $5,848 | $1,676 | 28.7% |
| 77321 | Radiation therapy total body port plan | Office | 2021 | 14 | 19 | $16,274 | $1,407 | 8.6% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2020 | 46 | 1,303 | $1.7M | $349,062 | 20.6% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2020 | 61 | 1,029 | $824,569 | $199,570 | 24.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2020 | 105 | 2,339 | $524,507 | $117,814 | 22.5% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Office | 2020 | 45 | 1,247 | $818,984 | $113,333 | 13.8% |
| 77301 | Management of modulation radiotherapy planning | Office | 2020 | 43 | 56 | $393,583 | $82,368 | 20.9% |
About Dr. Charles Thomas, MD
Dr. Charles Thomas, MD is a Radiation Oncology healthcare provider based in Clyde, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447200738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Thomas, MD has received a total of $2,150 in payments from pharmaceutical and medical device companies, with $91.40 received in 2020. These payments were reported across 138 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,150).
As a Medicare-enrolled provider, Thomas has provided services to 2,451 Medicare beneficiaries, totaling 16,315 services with total Medicare billing of $2.3M. Data is available for 2 years (2020–2021), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Clyde, NC
- Active Since 05/10/2006
- Last Updated 12/09/2009
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1447200738
Products in Payments
- VOTRIENT (Drug) $138.18
- Aranesp (Biological) $127.88
- Kyprolis (Biological) $109.48
- TrueBeam (Device) $106.97
- XTANDI (Drug) $101.41
- LYNPARZA (Drug) $94.73
- KISQALI (Drug) $91.03
- Neulasta (Biological) $71.83
- AFINITOR (Drug) $67.42
- Erleada (Drug) $65.54
- Lenvima (Drug) $60.34
- NINLARO (Drug) $60.10
- Cabometyx (Drug) $56.31
- Aliqopa (Drug) $55.61
- KEYTRUDA (Biological) $54.06
- JAKAFI (Drug) $42.53
- MEKINIST (Drug) $41.73
- Lonsurf (Drug) $40.63
- OPDIVO (Biological) $39.75
- Vitrakvi (Drug) $37.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.